- Report
- June 2025
- 400 Pages
Global
From €4486EUR$4,949USD£3,822GBP
- Report
- October 2023
- 146 Pages
Global
From €3009EUR$3,320USD£2,564GBP
€3762EUR$4,150USD£3,205GBP
- Report
- May 2025
- 141 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- May 2025
- 210 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- May 2023
- 95 Pages
Global
From €3500EUR$4,136USD£3,086GBP
Iodinated Contrast Media (ICM) is a type of contrast media used in medical imaging to enhance the visibility of organs, tissues, and vessels. It is typically administered intravenously, and is composed of iodine-based compounds that absorb X-rays and create a contrast between the area of interest and the surrounding tissue. ICM is used in a variety of medical imaging procedures, including computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
ICM is a critical component of medical imaging, as it allows for the accurate diagnosis of a variety of medical conditions. It is also used to monitor the progress of treatments, such as chemotherapy and radiation therapy.
The ICM market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Bayer, Bracco Imaging, Guerbet, GE Healthcare, Lantheus Medical Imaging, Mallinckrodt, and Siemens Healthineers. Show Less Read more